- Home
- HONE vs ORGO Comparison
HONE vs ORGO Comparison
Compare HONE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- ORGO
- Stock Information
- Founded
- HONE 1917
- ORGO 1985
- Country
- HONE United States
- ORGO United States
- Employees
- HONE N/A
- ORGO N/A
- Industry
- HONE Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- ORGO Health Care
- Exchange
- HONE Nasdaq
- ORGO Nasdaq
- Market Cap
- HONE 513.0M
- ORGO 465.6M
- IPO Year
- HONE 2016
- ORGO N/A
- Fundamental
- Price
- HONE $11.61
- ORGO $4.51
- Analyst Decision
- HONE Buy
- ORGO Buy
- Analyst Count
- HONE 3
- ORGO 2
- Target Price
- HONE $14.50
- ORGO $6.50
- AVG Volume (30 Days)
- HONE 258.2K
- ORGO 895.4K
- Earning Date
- HONE 07-24-2025
- ORGO 08-07-2025
- Dividend Yield
- HONE 3.10%
- ORGO N/A
- EPS Growth
- HONE 71.76
- ORGO N/A
- EPS
- HONE 0.65
- ORGO N/A
- Revenue
- HONE $164,819,000.00
- ORGO $458,760,000.00
- Revenue This Year
- HONE N/A
- ORGO $3.50
- Revenue Next Year
- HONE $9.44
- ORGO $8.59
- P/E Ratio
- HONE $17.88
- ORGO N/A
- Revenue Growth
- HONE N/A
- ORGO 5.35
- 52 Week Low
- HONE $8.89
- ORGO $2.28
- 52 Week High
- HONE $13.73
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- HONE 40.86
- ORGO 53.20
- Support Level
- HONE $11.97
- ORGO $4.67
- Resistance Level
- HONE $12.32
- ORGO $5.15
- Average True Range (ATR)
- HONE 0.25
- ORGO 0.28
- MACD
- HONE -0.08
- ORGO -0.04
- Stochastic Oscillator
- HONE 10.00
- ORGO 53.70
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.